MyFinsight

HomeAboutContact
Curious boy with magnifying glass
A worm made of letters APL
A worm made of letters BOA

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2024 MyFinsight. All rights reserved.

LABCORP HOLDINGS INC. (LH)

For the quarter ending 2025-06-30, LH made $3,527.3M in revenue. $237.9M in net income. Net profit margin of 6.74%.

Overview

Revenue
$3,527.3M
Net Income
$237.9M
Net Profit Margin
6.74%
EPS
$2.84
Unit: Million (M) dollars
Revenue Breakdown
    • Diagnostics-Operating Segments
    • Biopharma Laboratory Services-Op...

Unit: Million (M) dollars (except for numbers of shares and EPS)
2025-06-30
2025-03-31
2024-09-30
2024-06-30
Revenues3,527.3 3,345.1 3,282 3,220.9
Cost of revenues2,481.1 2,397.1 2,377.6 2,294.5
Gross profit1,046.2 948 904.4 926.4
Goodwill and other asset impairments- - - -
Amortization of intangibles and other assets68.3 69.6 63.7 62.2
Restructuring and other charges4.1 6.4 18 11.6
Selling, general, and administrative expenses579.3 546 568.6 557.8
Operating income394.5 326 254.1 294.8
Investment income1.7 6.5 3.1 1.3
Interest expense57.1 56 50.4 47.6
Equity method loss, net-1.7 -0.3 -0.5 -0.3
Other, net-32.7 -1 4.3 19.5
Earnings from operations before income taxes304.7 275.2 210.6 267.7
Provision for income taxes66.4 62.2 41 62.1
Income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest- - 169.6 205.6
Income (loss) from discontinued operations, net of tax, including portion attributable to noncontrolling interest- - - -
Net earnings238.3 213 169.6 205.6
Less net earnings attributable to the noncontrolling interest0.4 0.2 0.3 0.3
Net earnings attributable to labcorp holdings inc237.9 212.8 169.3 205.3
Basic earnings per share (in dollars per share)2.85 2.54 2.02 2.44
Diluted earnings per share (in dollars per share)2.84 2.52 2 2.43
Net earnings, basic (in shares)83,400,000 83,600,000 84,000,000 84,100,000
Weighted average number of shares outstanding, diluted83,900,000 84,300,000 84,400,000 84,300,000
Unit: Million (M) dollars (except for numbers of shares and EPS)

Income Statement

DownloadDownload image
Biopharma LaboratoryServices-Operating Segments$784.8M Diagnostics-Operating Segments$2,748.8M (8.87%↑ Y/Y)Revenues$3,527.3M (9.51%↑ Y/Y)Intersegment Elimination-$6.3M (42.73%↑ Y/Y)Gross profit$1,046.2M (12.93%↑ Y/Y)Cost of revenues$2,481.1M (8.13%↑ Y/Y)Investment income$1.7M (30.77%↑ Y/Y)Operating income$394.5M (33.82%↑ Y/Y)Restructuring and othercharges$4.1M (-64.66%↓ Y/Y)Amortization of intangiblesand other assets$68.3M (9.81%↑ Y/Y)Selling, general, andadministrative expenses$579.3M (3.85%↑ Y/Y)Earnings from operationsbefore income taxes$304.7M (13.82%↑ Y/Y)Equity method loss, net-$1.7M (-466.67%↓ Y/Y)Interest expense$57.1M (19.96%↑ Y/Y)Other, net-$32.7M (-267.69%↓ Y/Y)Net earnings$238.3M (15.90%↑ Y/Y)Provision for income taxes$66.4M (6.92%↑ Y/Y)Net earningsattributable to labcorp...$237.9M (15.88%↑ Y/Y)Less net earningsattributable to the...$0.4M (33.33%↑ Y/Y)